IN-DATE
CP-029: Corcym Carbomedics Carbo-Seal Valsalva Aortic Prosthesis 29mm
Sign in to add this product to your favorites!
| Price: | $234.50 per kit |
|---|---|
| Quantity: | |
| In Stock: | 1 kits |
| Status: | expired |
| Express: | Need it tomorrow? Order in next 5 hours 3 minutes and choose overnight shipping at checkout. |
Additional Details
Corcym Carbomedics Carbo-Seal Valsalva Ascending Aortic Prosthesis
- Valved Conduit with Woven Polyester Gelatin-Impregnated Graft and Pre-Attached Handle
- Vertical orientation of pleats facilitates coronary anastomosis
- Graft material resists fraying and quickly seals suture holes, minimizing bleeding
- Easier handling and suturing in comparison to bulkier velour materials
- Ultra-low porosity fabric results in less leakage, weeping and blushing
- Pliable, cork-shaped sewing cuff conforms to annulus, minimizing potential perivalvular leaks
- Titanium stiffening ring allows valve rotatability in-situ
AccessGUDID Info
- FDA Product Code: LWQ
- FDA Product Code Name: HEART-VALVE, MECHANICAL
- GMDN Term Code: 60423
- GMDN Term Name: Aortic bi-leaflet mechanical heart valve prosthesis/biologic-polymer aorta graft
- GMDN Term Description: An artificial substitute for a natural aortic heart valve fitted with a length of biologic-polymer blood vessel (vascular graft) intended to be implanted during open heart surgery to simultaneously replace a dysfunctional aortic heart valve and repair/replace a damaged or diseased ascending aorta (e.g., in cases of aneurysm, dissection or dilatation). The valve component consists of two flat, semicircular, pyrolytic carbon-coated or polymer leaflets that pivot about struts attached to the valve housing by hinges; the synthetic polymer blood vessel is designed to conform to the aortic root anatomy and is impregnated with a bioabsorbable animal-derived gelatin.
Manufacturer
Corcym is a global medical device company dedicated to structural heart therapies, with a focus on cardiac surgery. Formerly part of LivaNova, Corcym became an independent company to concentrate exclusively on surgical heart valve technologies. Its portfolio includes tissue valve solutions such as the Perceval sutureless aortic valve and the CROWN PRT bioprosthesis, designed to streamline implantation and improve durability. Corcym also offers mechanical valves, annuloplasty rings, and accessories that support both conventional and minimally invasive cardiac procedures. With a commitment to advancing outcomes in structural heart disease, Corcym partners with cardiac surgeons worldwide to deliver next-generation valve therapies.
